
An MP whose mother died of cancer days after her diagnosis has welcomed plans to link patients with clinical trials.
Allison Gardner said the Rare Cancers Bill “offers an entirely reasonable set of steps for research, for reviewing and hopefully enabling the development of so-called orphan drugs”.